SHENOGEN PHARMA GROUP LTD has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DONG ZHENG XIN, ARAIM PHARMACEUTICALS INC and ONCONOX APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Meng Kun | 9 |
#2 | Li Jin | 9 |
#3 | Kun Meng | 3 |
#4 | Jing Li | 1 |
#5 | Jin Li | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010091637A1 | Antibodies and methods for treating estrogen receptor-associated diseases | |
CN103755673A | Compound and method for treating estrogen receptor-related diseases | |
EP2262366A1 | Compounds and methods for treating estrogen receptor-related diseases | |
CN101185643A | Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine | |
WO2008052005A2 | Compounds and methods for treating estrogen receptor-related diseases | |
CN101302548A | Preparation of icaritin |